VRAX - Financial Reports List - Virax Biolabs Group Limited - IntrinsicAlpha

Virax Biolabs Group Limited VRAX

Healthcare - Biotechnology - NASDAQ - GB

$ 1.0

-5.45 %

$ 4.34 M

Market Cap

-0.4

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q2	8-K	2024-09-30	-14.01%	-90.94%	-99.84%
Quarterly Report	Q4	8-K	2024-03-31	186.06%	-230.67%	-224.80%
Annual Report	FY	10-K	2024-03-31	1727.11%	-23.38%	-13.32%
Quarterly Report	Q2	8-K	2023-09-30	0.00%	-426.71%	-377.51%
Quarterly Report	Q4	8-K	2023-03-31	-97.45%	-1205.21%	-1471.77%
Annual Report	FY	10-K	2023-03-31	0.00%	-219.37%	-230.67%
Quarterly Report	Q2	8-K	2022-09-30	-58.86%	-320.32%	-287.82%
Quarterly Report	Q4	8-K	2022-03-31	-371.92%	-553.37%	-616.75%
Annual Report	FY	10-K	2022-03-31	0.00%	-162.50%	-168.98%
Quarterly Report	Q2	8-K	2021-09-30	0.00%	0.00%	0.00%

1